“Designing Small-Molecule Allosteric Inhibitors of CYP2C19 to Prevent Clopidogrel Resistance in Patients With Specific Genetic Polymorphisms”, LMJHCR, vol. 3, no. 2, p. e76, Dec. 2025, doi: 10.61919/gsj6hy59.